Cargando…
Orally deliverable strategy based on microalgal biomass for intestinal disease treatment
Design of innovative strategies for oral drug delivery is particularly promising for intestinal disease treatment. However, many obstacles such as poor therapeutic efficacy and low bioavailability and biocompatibility remain to be addressed. Here, we report a versatile formulation based on a helical...
Autores principales: | Zhong, Danni, Zhang, Dongxiao, Chen, Wei, He, Jian, Ren, Chaojie, Zhang, Xingcai, Kong, Na, Tao, Wei, Zhou, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612690/ https://www.ncbi.nlm.nih.gov/pubmed/34818040 http://dx.doi.org/10.1126/sciadv.abi9265 |
Ejemplares similares
-
Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy
por: Zhang, Dongxiao, et al.
Publicado: (2022) -
Overexpression of the scopoletin biosynthetic pathway enhances lignocellulosic biomass processing
por: Hoengenaert, Lennart, et al.
Publicado: (2022) -
Interferon b drives intestinal regeneration after radiation
por: Leibowitz, Brian J., et al.
Publicado: (2021) -
Stromal BMP signaling regulates mucin production in the large intestine via interleukin-1/17
por: Wang, Yalong, et al.
Publicado: (2023) -
Milk-derived extracellular vesicles protect intestinal barrier integrity in the gut-liver axis
por: Tong, Lingjun, et al.
Publicado: (2023)